Enumeral is a biotechnology company that discovers and develops novel antibody immunotherapies to treat cancer, infectious and inflammatory diseases.
Business Model:
Revenue: $402.9k
Employees: 2-10
Address: 200 Cambridgepark Dr
City: Cambridge
State: MA
Zip: 02140
Country: US
Enumeral is a biotechnology company that discovers and develops novel antibody immunotherapies to treat cancer, infectious and inflammatory diseases.
Contact Phone:
+16179459146
Contact Email:
Listed Exchange:
OTCBB
IPO Date:
8/4/2014
Ticker Symbol:
ENUM
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2012 | Venture Round | $2.3M | 7/2014 | Equity | $25.1M | 5/2017 | Debt | $668k | 7/2014 | Private Placement | $21.5M | 12/2016 | Unattributed | $3.4M | 7/2016 | Debt | $3M | 8/2014 | Post-IPO Equity | 2 | $21.5M |
180 Degree Capital Montrose Capital Partners 180 Degree Capital Montrose Capital Partners |
5/2014 | Venture Round | $2M | 5/2011 | Series A | $2M | 5/2013 | Venture Round | $1.5M | 8/2016 | Post-IPO Debt | $3M | 2/2014 | Debt Financing | $635k | 1/2011 | Seed Round | 1 | - |
Bantam Group Bantam Group |
1/2011 | Seed Round | 1 | - |
Bantam Group Bantam Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|